Select Publications 2025
Garg S, Blanchet B, Nguyen Y, Hollnagel F, et al. Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring. Arthritis Rheumatol. 2025 Dec 9.
Lee JE, Mendel A, Malhamé I, et al. An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial. Rheumatology (Oxford). 2025 Nov 1;64(11):5707-5715.
Stanciu M, Lee JYL, McDonald EG, et al. Medication-related Hospitalizations in Patients with Systemic Lupus Erythematosus. Lupus Sci Med. 2025 Jan 30;12(1):e001362.
Select Publications 2024
Barber MRW, Ugarte-Gil MF, Hanly JG, et al. Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Ann Rheum Dis. 2024 Sep 30;83(10):1295-1303.
Select Publications 2023
Nguyen Y, Blanchet B, Urowitz MB, et al. Association between severe non-adherence to hydroxychloroquine and SLE flares, damage, and mortality in 660 patients from the SLICC Inception Cohort. Arthritis Rheumatol. 2023 Dec;75(12):2195-2206.
Clarke AE, Hanly JG, Urowitz MB, et al. Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling. Arthritis Care Res (Hoboken). 2023 Sep;75(9):1859-1870.
Select Publications 2022
Cotton T, Fritzler MJ, Choi MY, et al. Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis. Lupus. 2022 Oct;31(12):1477-1484.
Almeida-Brasil CC, Pineau CA, Vinet E, et al. Predictors of unsuccessful hydroxychloroquine tapering and discontinuation: Can we personalize decision-making in systemic lupus treatment? Arthritis Care Res (Hoboken). 2022 Jul;74(7):1070-1078.
Barbacki A, Rached-d'Astous N, Pineau CA, et al. Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus. J Clin Rheumatol. 2022 Mar 1;28(2):e488-e490.
Select Publications 2021
Bernatsky S, Ramsey-Goldman R, Urowitz MB, et al. Cancer risk in a large inception SLE cohort: Effects of demographics, smoking, and medications. Arthritis Care Res (Hoboken). 2021 Dec;73(12):1789-1795.
Liu JL, Pineau CA, Grenier LP, et al. Treatment patterns and control of hypertension in systemic lupus erythematosus (SLE): a cross-sectional study. BMJ Open. 2021 Nov 1;11(11):e048384.
Lambert-Fliszar F, Bernatsky S, Kalache F, et al. Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levels with azathioprine. Lupus Sci Med. 2021 Aug;8(1):e000519.
Select Publications 2020
Legge A, Kirkland S, Rockwood K, et al. Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis Rheumatol. 2020 Apr;72(4):658-666.
Hanly JG, Li Q, Su L, et al. Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study. Arthritis Rheumatol. 2020 Jan;72(1):67-77.
Legge A, Kirkland S, Rockwood K, et al. Construction of a frailty index as a novel health measure in systemic lupus erythematosus. J Rheumatol. 2020 Jan;47(1):72-81.
Select Publications 2019
Brailovski E, Vinet, E, Pineau CA, et al. Marital status and age of systemic lupus erythematous diagnosis: The potential for differences related to sex and gender. Lupus Sci Med. 2019 Aug 5;6(1):e000325.
Mendel A, Bernatsky S, Hanly JG, et al. Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort. Ann Rheum Dis. 2019 Jul;78(7):1010-1012.
Tessier-Cloutier B, Twa D, Baecklund E, et al. Cell-of-Origin in Diffuse Large B-Cell Lymphoma in Systemic Lupus Erythematosus: Molecular and Clinical Factors Associated with Survival. Lupus Sci Med. 2019 May 4;6(1):e000324.
Select Publications 2018
Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, et al. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. J Rheumatol. 2018 Oct;45(10):1426-1439.
Bernatsky S, Ramsey-Goldman R, Petri M, et al. Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus. J Rheumatol. 2018 Mar;45(3):393-396.
Couture J, Ben-Shoshan M, Pineau CA, et al. Risk of Allergic Conditions in Children Born to Women with Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2018 Feb;70(2):315-319.
Select Publications 2017
Bernatsky S, Ramsey-Goldman R, Petri M, et al. Breast cancer in systemic lupus. Lupus. 2017 Mar;26(3):311-315.
George A, Wong-Pak A, Peschken CA, et al Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus. Arthritis Care Res (Hoboken). 2017 Jan;69(1):124-132.
Select Publications 2016
Vinet É, Genest G, Scott S, et al. Brief Report: Causes of Stillbirths in Women With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016 Oct;68(10):2487-91.
Pope JE, Rothfield NF, Ramsey-Goldman R, et al. Hydroxychloroquine treatment in SLE. Arthritis Care Res. 2016 Jul;68(7):1053-4.
Urowitz MB, Gladman DD, Anderson NM, et al. Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort. Lupus Sci Med. 2016 Apr 12;3(1):e000143.
Select Publications 2015
Vinet É, Pineau CA, Clarke AE, et al Increased Risk of Autism Spectrum Disorders in Children Born to Women With Systemic Lupus Erythematosus: Results From a Large Population-Based Cohort. Arthritis Rheumatol. 2015 Dec;67(12):3201-8.
Hanly JG, Su L, Urowitz MB, et al. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2015 Jul;67(7):1837-47.
Vinet E, Pineau CA, Scott S, et al. Increased Congenital Heart Defects in Children Born to Women with Systemic Lupus Erythematosus: Results from the OSLER Study. Circulation. 2015;131: 149-56.
Moura CM, Li R, Lawrie S, et al. Humor in Systemic Lupus Erythematosus. Eur J Rheumatol 2015; 2: 5-9.
Select Publications 2014
Bourré-Tessier J, Urowitz MB, Clarke AE, et al. Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort. Arthritis Care Res. 2014 May 16. Arthritis Care Res (Hoboken). 2015 Jan;67(1):128-35.
Bernatsky S, Ramsey-Goldman R, Joseph L, et al. Lymphoma risk in systemic lupus: Effects of disease activity versus treatment. Ann Rheum Dis. 2014;73(1):138-42.
Urowitz M, Gladman DD, Ibañez D, et al. Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with SLE. Arthritis Care Res. 2014 Sep;66(9):1374-9.